Published in Liver Transpl on July 01, 2000
Hidden hazards of HCV transmission. Med Microbiol Immunol (2010) 0.89
Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg (2006) 0.80
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology (1994) 2.73
Immunosuppression, generic drugs and the FDA. Am J Transplant (2011) 2.43
Shipment of human islets for transplantation. Am J Transplant (2007) 2.01
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology (1993) 1.90
Total hepatectomy and liver replacement (orthotopic liver transplantation) for primary hepatic malignancy. World J Surg (1982) 1.84
End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation (2001) 1.79
Impact of pretransplant renal function on survival after liver transplantation. Transplantation (1995) 1.58
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
Readmission to the intensive care unit after liver transplantation. Crit Care Med (2001) 1.54
Metallic stents for the treatment of intrahepatic biliary strictures after liver transplantation. J Vasc Interv Radiol (1996) 1.51
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology (1998) 1.46
De novo hepatitis B infection after liver transplantation: source of disease, incidence, and impact. Liver Transpl Surg (1998) 1.42
The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors. Transplantation (1992) 1.41
Effect of pentoxifylline on hepatic ischemia and reperfusion injury. Surgery (1997) 1.41
Cyclosporin A hepatotoxicity in 66 renal allograft recipients. Transplantation (1981) 1.38
Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J Immunol (1995) 1.38
The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation (1990) 1.37
Pharmacokinetics of tacrolimus in liver transplant patients. Clin Pharmacol Ther (1995) 1.33
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant. Am J Transplant (2011) 1.29
Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome--experience in 300 patients. Transplantation (1991) 1.18
Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation (2001) 1.15
The elderly liver transplant recipient: a call for caution. Ann Surg (2001) 1.15
Results after liver retransplantation (RETx): a comparative study between "elective" vs "nonelective" RETx. Transplant Proc (1990) 1.14
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther (2007) 1.13
Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1,198 cases. Eur J Med Res (2007) 1.13
Problematic vascular reconstruction in liver transplantation. Part I. Arterial. Surgery (1990) 1.12
RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection. Ann Surg (1992) 1.11
Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation (2000) 1.10
Ten years of liver transplantation: an evolving understanding of late graft loss. Transplantation (1997) 1.10
Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome. Transplantation (1997) 1.09
The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet (1993) 1.08
De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients. Am J Transplant (2013) 1.07
Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. Clin Transplant (1998) 1.05
N-formylpeptide and complement C5a receptors are expressed in liver cells and mediate hepatic acute phase gene regulation. J Exp Med (1995) 1.05
Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation (1996) 1.05
Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery (1990) 1.04
Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg (1997) 1.04
Nephrotoxicity of cyclosporine in liver transplantation. Transplant Proc (1985) 1.04
A simple model to estimate survival after retransplantation of the liver. Transplantation (1999) 1.02
Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant (2005) 1.02
Late follow-up after thoracic duct drainage in cadaveric renal transplantation. Surg Gynecol Obstet (1981) 1.01
The impact of treatment of portopulmonary hypertension on survival following liver transplantation. Am J Transplant (2007) 1.01
Quality of life before and after liver transplantation for cholestatic liver disease. Hepatology (1999) 1.01
Early enteral nutrition support in patients undergoing liver transplantation. JPEN J Parenter Enteral Nutr (1996) 1.01
Combined liver-kidney transplantation: what are the indications? Transplantation (1997) 1.00
Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl (2000) 1.00
A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease. Hepatology (1997) 1.00
The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology (1999) 1.00
Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation. Exp Hematol (1997) 0.98
Preoperative volume prediction in adult living donor liver transplantation: how much can we rely on it? Am J Transplant (2007) 0.97
A comparison of UW with Eurocollins preservation solution in liver transplantation. Transplantation (1990) 0.96
The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant (2014) 0.96
Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation (1998) 0.96
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation (1992) 0.95
99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A. Radiology (1982) 0.95
Bortezomib for acute antibody-mediated rejection in liver transplantation. Am J Transplant (2012) 0.95
Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94
Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol (1984) 0.94
Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments. Eur J Med Res (2005) 0.94
Steps in immunosuppression for renal transplantation. Kidney Int Suppl (1983) 0.93
Transplant center regulations--a mixed blessing? An ASTS Council viewpoint. Am J Transplant (2008) 0.93
An unusual presentation of fulminant hepatic failure secondary to propylthiouracil therapy. Clin Transpl (1989) 0.92
Class II alloantibody and mortality in simultaneous liver-kidney transplantation. Am J Transplant (2013) 0.92
Alcohol use following liver transplantation for alcoholic cirrhosis. Transplantation (1996) 0.92
Cannulation of the aorta in organ donors with aortic and caval injuries at the time of procurement. Pediatr Transplant (2001) 0.91
Simultaneous heart and kidney transplantation: a report of three cases and review of the literature. J Heart Lung Transplant (1992) 0.89
Direct measurement of hepatic blood flow in native and transplanted organs, with accompanying systemic hemodynamics. Hepatology (1992) 0.89
Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis (1992) 0.88
Computer-assisted operative planning in adult living donor liver transplantation: a new way to resolve the dilemma of the middle hepatic vein. World J Surg (2007) 0.87
Does intraoperative hepatic artery flow predict arterial complications after liver transplantation? Transplantation (1998) 0.87
Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation (1997) 0.86
Simultaneous liver and renal transplantation in man. Transplantation (1988) 0.86
Quality of life improvements at one, two, and five years after liver transplantation. Transplantation (1995) 0.86
Is liver transplantation indicated for cholangiocarcinoma? J Hepatobiliary Pancreat Surg (1998) 0.85
p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons. Carcinogenesis (1996) 0.85
The safety of cardiac operations in the liver transplant recipient. Ann Thorac Surg (1998) 0.85
Liver transplantation for hilar cholangiocarcinoma: a German survey. Transplant Proc (2008) 0.85
Baylor update: outcome analysis in liver transplantation. Clin Transpl (1993) 0.85
Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. Transplant Proc (1995) 0.85
Survival after liver transplantation in 300 consecutive patients: the influence of age, clinical status, and pretransplant disease. Transplant Proc (1992) 0.85
Early complications after orthotopic liver transplantation. Surg Clin North Am (1999) 0.85
It is time to re-think 'extended criteria'. Am J Transplant (2006) 0.84
Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: prognostic factors in 196 tumors. Int J Radiat Oncol Biol Phys (1998) 0.84
A totally failing liver may be more harmful than no liver at all: three cases of total hepatic devascularization in preparation for emergency liver transplantation. Transplant Proc (1991) 0.83
FK506 conversion for intractable rejection of the liver allograft. Transpl Int (1993) 0.82
Colon carcinoma in patients undergoing liver transplantation. Am J Surg (1998) 0.82
Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience. Transplant Proc (2008) 0.82
Intensive care unit management of liver transplant patients: a formidable challenge for the intensivist. Transplant Proc (2008) 0.82
Liver transplantation for hepatocellular carcinoma in patients beyond the Milan but within the UCSF criteria. Eur J Med Res (2006) 0.82
Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome. Surg Gynecol Obstet (1992) 0.82
Territorial belonging of the middle hepatic vein in living liver donor candidates evaluated by three-dimensional computed tomographic reconstruction and virtual liver resection. Br J Surg (2009) 0.81
Results after liver retransplantation in a group of 50 regrafted patients: two different concepts of elective versus emergency retransplantation. Transpl Int (1991) 0.81